“an increasing trend”

The median length of stay was 11 (2016, 2019)–12 (2022) days ( Supplemental Figure S3a ), and median total charges showed an increasing trend, reaching $221,508 (IQR $98,710–$543,210) in 2022 (p < 0.001) ( Supplemental Figure S3b ).

No gender differences were observed in the prevalence of albuminuria (8.51% versus 8.41%; p = 0.747), and an increasing trend in the prevalence of albuminuria with advanced ages was seen in both genders ( p < 0.001 for females, p < 0.001 for males across age groups).

NTM isolation showed an increasing trend from 2016 to 2020 (p<0.001, test for trend) mainly caused by Mycobacterium avium complex.

An increasing trend in family support in clients’ participation in MMT was also observed (baseline, 64.5%; month one, 71.6%; month six, 77.8%; P < 0.001).

In addition, there was an increasing trend between the level of general health problems and PIU ( P <0.001).

An increasing trend of resistance to ampicillin was observed for E. faecalis (from 0% in 2010 to 0.4% in 2021), and for E. faecium (from 63.0% in 2010 to 77.7% in 2021; p < 0.001).

Figure 2 displays the Kaplan-Meier curves of cumulative incidence of diabetes according to quintiles of the ALT/HDL-C ratio, showing an increasing trend in cumulative incidence of diabetes with increasing quintiles of the ALT/HDL-C ratio (log-rank P < 0.001).

Resilience showed an increasing trend during the four tests (Slope = 0.56, p < 0.001), and the rate of increase increased month by month (Linear Slope = 0.28, p < 0.01).

Moreover, there was an increasing trend in the total number of keratoplasties performed (P < 0.001 using MARS).

Generally, we found an increasing trend concerning crude seropositivity with advancing age ( p < 0.001); however, differences were only significant when comparing the older age group 60–69 (5.2%; 95% confidence interval (CI) 4.5–5.9%) to the younger age group 20–29 (2.6%; 95%-CI 1.8–3.5%) (Table 1 ).

The mean age rates of patients were significantly different in various years with an increasing trend in time (p<0.001).

The percentage of teleconsultations showed an increasing trend over the years ( P = 0.001).

The balance of the pros and the cons showed an increasing trend in negative over positive attitudes toward smoking across the SoC ( F 2,249 = 9.2, p < 0.001). 3.3.

In this study, there was a significant difference between two groups regarding the requirement of propofol as rescue drug, with an increasing trend of using it in Group P ( P < 0.001).

There is no clear pattern of increase in UV Index in Sweden, England, and Australia ( p > 0.05); however, there was an increasing trend of UV index in the USA (β = 0.047; p < 0.001).

The prevalence of functional constipation showed an increasing trend from control, RBD-FDR, RBD to early PD patients (8.3 vs 9.4 vs 45.3 vs 69.4%, P value <0.001).

During the treatment period, the achievement of PASI 75, PASI 90, and PGA (1/0) showed an increasing trend ( Z =9.42 and P <.001; Z =8.53 and P <.001; and Z =3.14 and P =.002, respectively).

The use of multivitamin supplements differed according to BMI group, with an increasing trend for not using any supplements with higher BMI ( p < 0.001).

Moreover, ‘DRG payment cases’ performed an insignificant reduction in readmission rate, whereas FFS reversion cases exhibited an increasing trend (1.49%, P < 0.001) (Fig. 2 ).

There was an increasing trend for total treatment expenses from lower to higher RACHS categories (p < 0.001).

The variance explained by the first word component showed an increasing trend over stimulus repetitions for the NOVEL group (Fig. 6 b middle); a linear regression showed that this increase was a significant effect ( t (6) = 5.852, p = 0.001).

Chi-square tests for trend showed that the overweight and obesity rates of preschool children in Fujian Province presented an increasing trend with the increase in age ( p < 0.001).

And the prevalence showed an increasing trend along with seven survey waves over the past 16 years (p < 0.001).

The overall prevalence of anemia in dogs with DMVD was 14.9%, with prevalence showing an increasing trend from class II (0%) to class III (15.2%) to class IV (33.3%, p < 0.001, Table 2 ).

Coverage with the tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine varied between 49.8% in 2016 and 79.4% in 2018, following an increasing trend ( p < 0.001).